annual FCF:
$4.57B-$939.74M(-17.07%)Summary
- As of today (May 19, 2025), GSK annual free cash flow is $4.57 billion, with the most recent change of -$939.74 million (-17.07%) on December 31, 2024.
- During the last 3 years, GSK annual FCF has fallen by -$2.72 billion (-37.37%).
- GSK annual FCF is now -51.94% below its all-time high of $9.50 billion, reached on December 31, 2008.
Performance
GSK Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$877.62M-$593.21M(-40.33%)Summary
- As of today (May 19, 2025), GSK quarterly free cash flow is $877.62 million, with the most recent change of -$593.21 million (-40.33%) on March 31, 2025.
- Over the past year, GSK quarterly FCF has increased by +$376.61 million (+75.17%).
- GSK quarterly FCF is now -81.52% below its all-time high of $4.75 billion, reached on December 31, 2018.
Performance
GSK quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$4.94B+$376.61M(+8.25%)Summary
- As of today (May 19, 2025), GSK TTM free cash flow is $4.94 billion, with the most recent change of +$376.61 million (+8.25%) on March 31, 2025.
- Over the past year, GSK TTM FCF has dropped by -$1.64 billion (-24.95%).
- GSK TTM FCF is now -53.15% below its all-time high of $10.55 billion, reached on June 30, 2010.
Performance
GSK TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
GSK Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.1% | +75.2% | -24.9% |
| 3 y3 years | -37.4% | -66.8% | -50.4% |
| 5 y5 years | -39.0% | +10.3% | -36.7% |
GSK Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -37.4% | at low | -70.3% | +251.7% | -51.8% | +77.7% |
| 5 y | 5-year | -45.2% | at low | -80.2% | +251.7% | -51.8% | +77.7% |
| alltime | all time | -51.9% | +3342.8% | -81.5% | +118.0% | -53.1% | +537.2% |
GSK Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $877.62M(-40.3%) | $4.94B(+8.2%) |
| Dec 2024 | $4.57B(-17.1%) | $1.47B(-15.9%) | $4.57B(-24.6%) |
| Sep 2024 | - | $1.75B(+107.3%) | $6.05B(-6.6%) |
| Jun 2024 | - | $843.95M(+68.4%) | $6.48B(-1.6%) |
| Mar 2024 | - | $501.01M(-83.1%) | $6.58B(+19.6%) |
| Dec 2023 | $5.50B(-13.6%) | $2.96B(+36.0%) | $5.50B(+30.4%) |
| Sep 2023 | - | $2.18B(+129.3%) | $4.22B(+51.7%) |
| Jun 2023 | - | $949.07M(-264.0%) | $2.78B(-11.6%) |
| Mar 2023 | - | -$578.58M(-134.6%) | $3.15B(-50.6%) |
| Dec 2022 | $6.37B(-12.6%) | $1.67B(+127.1%) | $6.37B(-30.1%) |
| Sep 2022 | - | $737.05M(-43.9%) | $9.12B(-11.0%) |
| Jun 2022 | - | $1.31B(-50.3%) | $10.25B(+2.8%) |
| Mar 2022 | - | $2.65B(-40.2%) | $9.97B(+36.7%) |
| Dec 2021 | $7.29B(-12.6%) | $4.42B(+137.1%) | $7.29B(+3.0%) |
| Sep 2021 | - | $1.87B(+80.9%) | $7.08B(+25.4%) |
| Jun 2021 | - | $1.03B(-3352.1%) | $5.64B(-24.9%) |
| Mar 2021 | - | -$31.71M(-100.8%) | $7.51B(-9.9%) |
| Dec 2020 | $8.34B(+11.5%) | $4.21B(+878.3%) | $8.34B(+8.3%) |
| Sep 2020 | - | $430.57M(-85.1%) | $7.70B(-21.0%) |
| Jun 2020 | - | $2.90B(+264.1%) | $9.74B(+24.8%) |
| Mar 2020 | - | $795.95M(-77.7%) | $7.81B(+4.4%) |
| Dec 2019 | $7.48B(-15.4%) | $3.57B(+44.4%) | $7.48B(-13.6%) |
| Sep 2019 | - | $2.47B(+157.0%) | $8.65B(+5.1%) |
| Jun 2019 | - | $962.73M(+105.8%) | $8.23B(-4.3%) |
| Mar 2019 | - | $467.69M(-90.1%) | $8.60B(-2.7%) |
| Dec 2018 | $8.84B(+45.2%) | $4.75B(+131.1%) | $8.84B(+28.6%) |
| Sep 2018 | - | $2.05B(+54.4%) | $6.88B(+2.8%) |
| Jun 2018 | - | $1.33B(+88.4%) | $6.69B(+13.5%) |
| Mar 2018 | - | $706.38M(-74.6%) | $5.89B(-3.2%) |
| Dec 2017 | $6.09B(+8.4%) | $2.78B(+49.0%) | $6.09B(-4.9%) |
| Sep 2017 | - | $1.87B(+249.1%) | $6.41B(+4.5%) |
| Jun 2017 | - | $535.18M(-40.6%) | $6.13B(-8.3%) |
| Mar 2017 | - | $901.66M(-70.9%) | $6.68B(+19.0%) |
| Dec 2016 | $5.62B(+450.1%) | $3.10B(+94.8%) | $5.62B(+48.7%) |
| Sep 2016 | - | $1.59B(+46.1%) | $3.78B(+68.6%) |
| Jun 2016 | - | $1.09B(-756.2%) | $2.24B(+164.4%) |
| Mar 2016 | - | -$166.06M(-113.2%) | $847.22M(-17.0%) |
| Dec 2015 | $1.02B(-81.9%) | $1.26B(+2174.4%) | $1.02B(-57.4%) |
| Sep 2015 | - | $55.45M(-118.3%) | $2.40B(-36.1%) |
| Jun 2015 | - | -$303.21M(-4100.7%) | $3.75B(-20.1%) |
| Mar 2015 | - | $7.58M(-99.7%) | $4.70B(-16.8%) |
| Dec 2014 | $5.65B(-34.6%) | $2.64B(+87.4%) | $5.65B(-0.9%) |
| Sep 2014 | - | $1.41B(+119.2%) | $5.70B(-16.6%) |
| Jun 2014 | - | $642.38M(-32.8%) | $6.83B(-16.2%) |
| Mar 2014 | - | $956.35M(-64.5%) | $8.15B(-5.7%) |
| Dec 2013 | $8.64B(+90.9%) | $2.69B(+6.0%) | $8.64B(+5.9%) |
| Sep 2013 | - | $2.54B(+29.7%) | $8.16B(+79.4%) |
| Jun 2013 | - | $1.96B(+35.6%) | $4.55B(-4.8%) |
| Mar 2013 | - | $1.44B(-34.7%) | $4.78B(+5.6%) |
| Dec 2012 | $4.52B(-42.7%) | $2.21B(-307.1%) | $4.52B(-9.3%) |
| Sep 2012 | - | -$1.07B(-148.8%) | $4.99B(-41.3%) |
| Jun 2012 | - | $2.19B(+84.2%) | $8.50B(+7.2%) |
| Mar 2012 | - | $1.19B(-55.5%) | $7.93B(+0.5%) |
| Dec 2011 | $7.89B | $2.67B(+9.4%) | $7.89B(+16.8%) |
| Sep 2011 | - | $2.45B(+50.6%) | $6.76B(+24.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | - | $1.62B(+41.1%) | $5.42B(-14.1%) |
| Mar 2011 | - | $1.15B(-25.3%) | $6.31B(-20.7%) |
| Dec 2010 | $7.96B(-14.9%) | $1.54B(+39.7%) | $7.96B(-7.8%) |
| Sep 2010 | - | $1.10B(-56.2%) | $8.63B(-18.1%) |
| Jun 2010 | - | $2.52B(-10.2%) | $10.55B(+3.3%) |
| Mar 2010 | - | $2.80B(+26.4%) | $10.21B(+9.2%) |
| Dec 2009 | $9.35B(-1.6%) | $2.22B(-26.5%) | $9.35B(-1.4%) |
| Sep 2009 | - | $3.02B(+38.5%) | $9.48B(+6.6%) |
| Jun 2009 | - | $2.18B(+12.4%) | $8.90B(+4.7%) |
| Mar 2009 | - | $1.94B(-17.4%) | $8.50B(-10.5%) |
| Dec 2008 | $9.50B(+18.0%) | $2.35B(-3.6%) | $9.50B(+9.9%) |
| Sep 2008 | - | $2.43B(+36.7%) | $8.64B(-8.8%) |
| Jun 2008 | - | $1.78B(-39.4%) | $9.47B(+1.0%) |
| Mar 2008 | - | $2.94B(+96.9%) | $9.38B(+16.5%) |
| Dec 2007 | $8.05B(+57.8%) | $1.49B(-54.3%) | $8.05B(-7.7%) |
| Sep 2007 | - | $3.26B(+93.6%) | $8.72B(+107.9%) |
| Jun 2007 | - | $1.69B(+4.9%) | $4.19B(+5.1%) |
| Mar 2007 | - | $1.61B(-25.7%) | $3.99B(-21.7%) |
| Dec 2006 | $5.10B(-41.3%) | $2.16B(-271.6%) | $5.10B(-2.1%) |
| Sep 2006 | - | -$1.26B(-185.0%) | $5.21B(-39.0%) |
| Jun 2006 | - | $1.48B(-45.4%) | $8.54B(-10.1%) |
| Mar 2006 | - | $2.72B(+19.5%) | $9.49B(+9.3%) |
| Dec 2005 | $8.69B(+21.6%) | $2.27B(+10.0%) | $8.69B(+20.8%) |
| Sep 2005 | - | $2.07B(-15.2%) | $7.19B(+9.6%) |
| Jun 2005 | - | $2.44B(+27.5%) | $6.56B(-4.6%) |
| Mar 2005 | - | $1.91B(+146.4%) | $6.88B(-3.8%) |
| Dec 2004 | $7.15B(+9.7%) | $775.96M(-45.9%) | $7.15B(+50.2%) |
| Sep 2004 | - | $1.43B(-47.9%) | $4.76B(-28.5%) |
| Jun 2004 | - | $2.75B(+26.2%) | $6.65B(-7.9%) |
| Mar 2004 | - | $2.18B(-235.4%) | $7.22B(+10.9%) |
| Dec 2003 | $6.52B(+136.4%) | -$1.61B(-148.4%) | $6.52B(+100.9%) |
| Sep 2003 | - | $3.33B(+0.1%) | $3.24B(+4.9%) |
| Jun 2003 | - | $3.32B(+125.7%) | $3.09B(+25.7%) |
| Mar 2003 | - | $1.47B(-130.2%) | $2.46B(-10.8%) |
| Dec 2002 | $2.76B(-45.2%) | -$4.88B(-253.7%) | $2.76B(-60.9%) |
| Sep 2002 | - | $3.18B(+18.1%) | $7.04B(+18.6%) |
| Jun 2002 | - | $2.69B(+52.1%) | $5.94B(+5.3%) |
| Mar 2002 | - | $1.77B(-395.8%) | $5.64B(+12.1%) |
| Dec 2001 | $5.03B(+343.0%) | -$598.36M(-128.9%) | $5.03B(+310.2%) |
| Sep 2001 | - | $2.07B(-13.5%) | $1.23B(-56.7%) |
| Jun 2001 | - | $2.39B(+106.3%) | $2.83B(+264.9%) |
| Mar 2001 | - | $1.16B(-126.4%) | $775.54M(-31.7%) |
| Dec 2000 | $1.14B(-906.4%) | -$4.40B(-219.7%) | $1.14B(-79.5%) |
| Sep 2000 | - | $3.68B(+979.9%) | $5.54B(+197.5%) |
| Jun 2000 | - | $340.38M(-77.6%) | $1.86B(+22.4%) |
| Mar 2000 | - | $1.52B | $1.52B |
| Dec 1999 | -$140.78M(+30.7%) | - | - |
| Dec 1998 | -$107.73M(-132.9%) | - | - |
| Dec 1997 | $327.65M(-53.2%) | - | - |
| Dec 1996 | $699.73M(-22.0%) | - | - |
| Dec 1995 | $896.54M(-71.1%) | - | - |
| Jun 1995 | $3.10B(+333.1%) | - | - |
| Jun 1994 | $715.41M(+38.0%) | - | - |
| Jun 1993 | $518.52M(+367.9%) | - | - |
| Jun 1992 | $110.82M(+563.6%) | - | - |
| Jun 1991 | $16.70M | - | - |
FAQ
- What is GSK annual free cash flow?
- What is the all time high annual FCF for GSK?
- What is GSK annual FCF year-on-year change?
- What is GSK quarterly free cash flow?
- What is the all time high quarterly FCF for GSK?
- What is GSK quarterly FCF year-on-year change?
- What is GSK TTM free cash flow?
- What is the all time high TTM FCF for GSK?
- What is GSK TTM FCF year-on-year change?
What is GSK annual free cash flow?
The current annual FCF of GSK is $4.57B
What is the all time high annual FCF for GSK?
GSK all-time high annual free cash flow is $9.50B
What is GSK annual FCF year-on-year change?
Over the past year, GSK annual free cash flow has changed by -$939.74M (-17.07%)
What is GSK quarterly free cash flow?
The current quarterly FCF of GSK is $877.62M
What is the all time high quarterly FCF for GSK?
GSK all-time high quarterly free cash flow is $4.75B
What is GSK quarterly FCF year-on-year change?
Over the past year, GSK quarterly free cash flow has changed by +$376.61M (+75.17%)
What is GSK TTM free cash flow?
The current TTM FCF of GSK is $4.94B
What is the all time high TTM FCF for GSK?
GSK all-time high TTM free cash flow is $10.55B
What is GSK TTM FCF year-on-year change?
Over the past year, GSK TTM free cash flow has changed by -$1.64B (-24.95%)